Viewing Study NCT00095966


Ignite Creation Date: 2025-12-24 @ 4:40 PM
Ignite Modification Date: 2026-02-04 @ 8:33 PM
Study NCT ID: NCT00095966
Status: COMPLETED
Last Update Posted: 2013-07-02
First Post: 2004-11-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adenocarcinoma of the Pancreas View
None Recurrent Pancreatic Cancer View
None Stage II Pancreatic Cancer View
None Stage III Pancreatic Cancer View
None Stage IV Pancreatic Cancer View
Keywords: